Ten-year conditional recurrence risks and overall and relative survival for breast cancer patients in the Netherlands: Taking account of event-free years

2018 ◽  
Vol 102 ◽  
pp. 82-94 ◽  
Author(s):  
Marissa C. van Maaren ◽  
Luc J.A. Strobbe ◽  
Marjolein L. Smidt ◽  
Martine Moossdorff ◽  
Philip M.P. Poortmans ◽  
...  
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Cancer Patients ◽  
Relative Survival ◽  
Breast Cancer Patients

Socioeconomic differences in survival among breast cancer patients in the Netherlands not explained by tumor size

2010 ◽  
Vol 127 (3) ◽  
pp. 721-727 ◽  
Author(s):  
E. Bastiaannet ◽  
A. J. M. de Craen ◽  
P. J. K. Kuppen ◽  
M. J. Aarts ◽  
L. G. M. van der Geest ◽  
...  
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Cancer Patients ◽  
Tumor Size ◽  
Socioeconomic Differences ◽  
Breast Cancer Patients

scholarly journals FOLLOW-UP OF PATIENTS AND PROGNOSTIC IMPACT OF TUMOUR MARKER CA 15-3 ON PATIENTS OF BREAST CANCER: A RETROSPECTIVE COHORT STUDY

2020 ◽  
Vol 8 (11) ◽  
pp. 656-660
Author(s):  
Anjali Vinocha ◽  
Keyword(s):  
Breast Cancer ◽  
Cohort Study ◽  
Cancer Patients ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Relative Survival ◽  
Rank Test ◽  
Prognostic Impact ◽  
Breast Cancer Patients

Introduction:Breast cancer is the most common cancer in women, with 5- and 10-year relative survival rates are 91% and 84%, respectively for women with invasive breast cancer. This study aimed to detect the role of serum breast cancer marker CA 15-3 for early detection of metastasis, relapse or recurrence for management of breast cancer patients. Methods: It was a retrospective cohort study with a total of 132 breast cancer patients from the year 2010 to march 2020 were taken and followed up. For these patients demographic, biochemical parameters, radiological and clico-pathological data were collected and analysed. Result: The mean age at the time of presentation and mean duration of follow-up was 47 years and 31 months respectively. There was elevation in the serum level of CA 15-3 at the time of diagnosis of metastasis, recurrence or residual disease in 41 patients. This shows that sensitivity of elevated CA 15-3 (> 30 IU/ml) level in Ca Breast patients was 84%, 75 % and 75 % with respect to metastasis, recurrence and relapse. Log Rank test Chi- square value was 7.39 which was statistically significant (p=0.007). Cox proportional hazard model was created for effect of age at presentation, CA 15-3 at the time of diagnosis and MRM on distant metastasis and was statistically significant (p=0.037). Conclusion: We recommend that for the management of breast cancer patients, Cancer antigen (CA 15-3) levels can be used as prognostic marker for early diagnosis of metastasis, recurrence or relapse.

36 Implementation of adjuvant trastuzumab in breast cancer patients in the Netherlands

2010 ◽  
Vol 8 (3) ◽  
pp. 69
Author(s):  
L. de Munck ◽  
M. Schaapveld ◽  
S. Siesling ◽  
R. Otter ◽  
P.H.B. Willemse
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Cancer Patients ◽  
Breast Cancer Patients ◽  
Adjuvant Trastuzumab

An actualised population‐based study on the use of radiotherapy in breast cancer patients in the Netherlands

2019 ◽  
Vol 25 (5) ◽  
pp. 942-947 ◽  
Author(s):  
Kay Schreuder ◽  
Judith G. Middelburg ◽  
Mieke J. Aarts ◽  
Jos W. S. Merkus ◽  
Philip M. P. Poortmans ◽  
...  
Keyword(s):  
Breast Cancer ◽  
The Netherlands ◽  
Cancer Patients ◽  
Population Based ◽  
Breast Cancer Patients ◽  
Population Based Study

scholarly journals Relative Survival of Breast Cancer Patients in Iran

2015 ◽  
Vol 16 (14) ◽  
pp. 5853-5858 ◽  
Author(s):  
Amir Kasaeian ◽  
Alireza Mosavi-Jarrahi ◽  
Alireza Abadi ◽  
Mahmood Mahmoodi ◽  
Yadollah Mehrabi ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cancer Patients ◽  
Relative Survival ◽  
Breast Cancer Patients
Sign in / Sign up

Export Citation Format

Share Document